Albert Labs International (XCNQ:ABRT) Total Stockholders Equity : C$-0.44 Mil (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Total Stockholders Equity?

Albert Labs International's Total Stockholders Equity for the quarter that ended in Sep. 2023 was C$-0.44 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Albert Labs International's Book Value per Share for the quarter that ended in Sep. 2023 was C$-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Albert Labs International's Debt-to-Equity for the quarter that ended in Sep. 2023 was -0.02.

Albert Labs International Total Stockholders Equity Historical Data

The historical data trend for Albert Labs International's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Total Stockholders Equity Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Total Stockholders Equity

-0.50

-0.37

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial					0.19	-0.37	-0.38	-0.43	-0.44

Albert Labs International (XCNQ:ABRT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Albert Labs International's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.443	-	0)	/	74.4133
	=	-0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Albert Labs International's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.01)	/	-0.443
	=	-0.02

Albert Labs International Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines